Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT00994916
Expanded Access Status : Available
First Posted : October 14, 2009
Last Update Posted : October 9, 2018
Jacobus Pharmaceutical
Information provided by (Responsible Party):
David Lacomis, MD, University of Pittsburgh

No Study Results Posted on for this Study
  Expanded Access Status : Available
  Primary Completion Date : No date given
  Study Completion Date : No date given